Title
Durability of Response in Plaque Psoriasis Patients Treated with Certolizumab Pegol: Two Year Data from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials
Document Type
Abstract
Publication Date
10-2019
Department
Dermatology
Recommended Citation
Gordon, K., Reich, K., Blauvelt, A., Thaci, D., Leonardi, C., Poulin, Y., Boehnlein, M., Kavanagh, S., Arendt, C., & Gottlieb, A. B. (2019). Durability of Response in Plaque Psoriasis Patients Treated with Certolizumab Pegol: Two Year Data from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. Journal of the American Academy of Dermatology, 81 (4 Suppl. 1), AB195. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/255
COinS
